Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
23-26 March, 2026
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Not Confirmed
Not Confirmed
12-14 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
23-26 March, 2026
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Industry Trade Show
Not Confirmed
12-14 January, 2026
Digital content

12 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/11/3204367/0/en/Cycle-Pharmaceuticals-to-Acquire-Applied-Therapeutics.html

20 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/20/3169815/0/en/Onco360-Has-Been-Selected-as-a-Specialty-Pharmacy-Partner-for-PHYRAGO-dasatinib.html

16 Oct 2025
// PHARMIWEB
https://www.pharmiweb.com/press-release/2025-10-16/cycle-pharmaceuticals-launches-its-first-oncology-product-phyrago-dasatinib-tablets-in-the-us

21 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250721000805/en/Cycle-Pharmaceuticals-Selects-LeMed-Specialty-Pharmacy-as-Exclusive-U.S.-Specialty-Pharmacy-Distribution-and-Services-Partner-for-HARLIKU-nitisinone-Tablets-the-First-and-only-FDA-approved-Treatment-for-Adult-Patients-with-Alkaptonuria-AKU

21 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250718163510/en/Cycle-Pharmaceuticals-Signs-Exclusive-U.S.-Sales-License-for-PHYRAGO-dasatinib-Tablets

21 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cycle-pharmaceuticals-selects-lemed-specialty-pharmacy-as-exclusive-us-specialty-pharmacy-distribution-and-services-partner-for-harliku-nitisinone-tablets-the-first-and-only-fda-approved-treatment-for-reducing-urinary-homoge-302506082.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE